International Biotechnology (LON:IBT) Announces Earnings Results

International Biotechnology (LON:IBT) released its quarterly earnings data on Tuesday. The company reported GBX (10.22) earnings per share (EPS) for the quarter, Digital Look Earnings reports. International Biotechnology had a return on equity of 27.35% and a net margin of 82.27%. The business had revenue of GBX 46 million for the quarter.

International Biotechnology Stock Down 0.5%

IBT stock traded down GBX 5 during trading on Tuesday, hitting GBX 1,030. 14,810 shares of the company’s stock were exchanged, compared to its average volume of 69,695. The business has a 50-day moving average price of GBX 1,080.85 and a two-hundred day moving average price of GBX 1,009.76. The company has a current ratio of 0.11, a quick ratio of 0.32 and a debt-to-equity ratio of 9.43. The stock has a market capitalization of £326.03 million, a price-to-earnings ratio of 4.26 and a beta of 0.47. International Biotechnology has a 52-week low of GBX 812 and a 52-week high of GBX 1,235.

International Biotechnology Company Profile

The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies.

The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology. Investments may also be made in related sectors such as medical devices and healthcare services.